Advanced search
Publication Cover
Comments on Inorganic Chemistry
A Journal of Critical Discussion of the Current Literature
Volume 38, 2018 - Issue 6
Submit an article Journal homepage
1,045
Views
23
CrossRef citations to date
0
Altmetric
Review Articles

Metal–Organic Frameworks and Covalent Organic Frameworks as Platforms for Photodynamic Therapy

Yoshie SakamakiDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, USAView further author information
,
John OzdemirDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, USAView further author information
,
Zachary HeidrickDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, USAView further author information
,
Olivia WatsonDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, USAView further author information
,
Hamid R. ShahsavariDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, USA;Department of Chemistry, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, IranView further author information
,
Masood FereidoonnezhadToxicology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranView further author information
,
Ahmad R. KhosropourDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, USA;Department of Chemistry, University of Isfahan, Isfahan, IranView further author information
&
M. Hassan BeyzaviDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, USACorrespondence[email protected]
View further author information
 show all
Pages 238-293 | Published online: 02 Feb 2019

References

  • Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R. L.; Torre, L. A.; Jemal, A., Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018, 3–31. DOI: 10.3322/caac.21442.
  • Allison, R. R.; Downie, G. H.; Cuenca, R.; Hu, X.; Childs, C.; Sibata, C. H., Photosensitizers in Clinical PDT. Photodiagnosis Photodyn. Ther. 2004, 1, 27–42. DOI: 10.1016/S1572-1000(04)00007-9.
  • Matsumura, Y.; Maeda, H. A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs. Cancer Res. 1986, 46, 6387–6392.
  • Maeda, H.;, The Enhanced Permeability and Retention (EPR) Effect in Tumor Vasculature: The Key Role of Tumor-Selective Macromolecular Drug Targeting. Adv. Enzyme Regul. 2001, 41, 189–207. DOI: 10.1016/S0065-2571(00)00013-3.
  • Maeda, H.; Matsuura, Y. Tumoritropic and Lymphotropic Principles of Macromolecular Drugs. Crit. Rev. Ther. Drug Carrier Syst. 1989, 6, 193–210.
  • Oku, N.; Tokudome, Y.; Tsukada, H.; Okada, S., Real-Time Analysis of Liposomal Trafficking in Tumor-Bearing Mice by Use of Positron Emission Tomography. Biochim. Biophys. Acta. 1995, 1238, 86–90. DOI: 10.1016/0005-2736(95)00106-D.
  • Cabral, H.; Matsumoto, Y.; Mizuno, K.; Chen, Q.; Murakami, M.; K, M.; Terada, Y.; Kano, M. R.; Miyazono, K.; Uesaka, M.; et al., Accumulation of Sub-100 Nm Polymeric Micelles in Poorly Permeable Tumours Depends on Size. Nat. Nanotech. 2011, 6, 815–823. DOI: 10.1038/nnano.2011.166.
  • Sykes, E. A.; Chen, J.; Zheng, G.; Chan, W. C., Investigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency. ACS Nano. 2014, 8, 5696–5706. DOI: 10.1021/nn500299p.
  • Byrne, J. D.; Betancourt, T.; Brannon-Peppas, L., Active Targeting Schemes for Nanoparticle Systems in Cancer Therapeutics. Adv. Drug. Deliv. Rev. 2008, 60, 1615–1626. DOI: 10.1016/j.addr.2008.08.005.
  • Sharman, W. M.; Allen, C. M.; van Lier, J. E., Photodynamic Therapeutics: Basic Principles and Clinical Applications. Drug Discov. Today. 1999, 4, 507–517. DOI: 10.1016/S1359-6446(99)01412-9.
  • Ashur, I.; Goldschmidt, R.; Pinkas, I.; Salomon, Y.; Szewczyk, G.; Sarna, T.; Scherz, A., Photocatalytic Generation of Oxygen Radicals by the Water-Soluble Bacteriochlorophyll Derivative WST11, Noncovalently Bound to Serum Albumin. J. Phys. Chem. 2009, 113, 8027–8037. DOI: 10.1021/jp900580e.
  • Mroz, P.; Tegos, G. P.; Gali, H.; Wharton, T.; Sarna, T.; Hamblin, M. R., Photodynamic Therapy with Fullerenes. Photochem. Photobio Sci. 2007, 6, 1139–1149. DOI: 10.1039/b711141j.
  • Yang, Y.; Bazhin, A. V.; Werner, J.; Karakhanova, S., Reactive Oxygen Species in the Immune System. Int. Rev. Immunol. 2013, 32, 249–270. DOI: 10.3109/08830185.2012.755176.
  • Chen, X.; Song, M.; Zhang, B.; Zhang, Y., Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment. Oxid. Med. Cell Longev. 2016, 1–10. DOI: 10.1155/2016/1580967.
  • Lee, S. H.; Almutairi, S.; Ali, A. K. Reactive Oxygen Species Modulate Immune Cell Effector Function.J.Immunol.2017,198 URL: http://www.jimmunol.org/content/198/1_Supplement/222.20.
  • Lucky, S. S.; Soo, K. C.; Zhang, Y., Nanoparticles in Photodynamic Therapy. Chem. Rev. 2015, 115, 1990–2042. DOI: 10.1021/cr5004198.
  • Ethirajan, M.; Chen, Y.; Joshi, P.; Pandey, R. K., The Role of Porphyrin Chemistry in Tumor Imaging and Photodynamic Therapy. Chem. Soc. Rev. 2011, 40, 340–362. DOI: 10.1039/b915149b.
  • Mehraban, N.; Freeman, H. S., Developments in PDT Sensitizers for Increased Selectivity and Singlet Oxgyen Production. Materials. 2015, 8, 4421–4456. DOI: 10.3390/ma8074421.
  • Vatansever, F.; Chandran, R.; Sadasivam, M.; Chiang, L.-Y.; Hamblin, M.-R. Multi-Functionality in Theranostic Nanoparticles: Is More Always Better. J. Nanomed. Nanotechol. 2012, 3. DOI: 10.4172/2157-7439.1000e120.
  • Tran, S.; DeGiovanni, P.-J.; Piel, B.; Rai, P., Cancer Nanomedicine: A Review of Recent Success in Drug Delivery. Clin. Trans. Med. 2017, 6, 556–562. DOI: 10.1186/s40169-017-0175-0.
  • Lismont, M.; Dreesen, L.; Wuttke, S. Metal-Organic Framework Nanoparticles in Photodynamic Therapy: Current Status and Perspectives. Adv. Func. Mater. 2017, 27. DOI: 10.1002/adfm.201606314.
  • Tseng, S.-H.; Chou, M.-Y.; Chu, I.-M., Cetuximab-Conjugated Iron Oxide Nanoparticles for Cancer Imaging and Therapy. Int. J. Nanomedicine. 2015, 10, 3663–3685. DOI: 10.2147/IJN.S80134.
  • Cao, J.; Chen, Z.; Chi, J.; Sun, Y.; Sun, Y. Recent Progress in Synergistic Chemotherapy Andphototherapy by Targeted Drug Delivery Systemsfor Cancer Treatment. Artif. Cells, Nanomedicine, Biotechnol. 2018, 1–14. DOI: 10.1080/21691401.2018.1436553.
  • Liu, T.; Jia, T.; Yuan, X.; Liu, C.; Sun, J.; Ni, Z.; Xu, J.; Wang, X.; Yuan, Y., Development of Octreotide-Conjugated Polymeric Prodrug of Bufalin for Targeted Delivery to Somatostatin Receptor 2 Overexpressing Breast Cancer in Vitro and in Vivo. Int. J. Nanomedicine. 2016, 11, 2235–2250. DOI: 10.2147/IJN.S100404.
  • Park, J. H.; Lee, S.; Kim, J.-H.; Park, K.; Kim, K.; Kwon, I. C., Polymeric Nanomedicine for Cancer Therapy. Prog. Polymer. Sci. 2008, 33, 113–137. DOI: doi:10.1016/j.progpolymsci.2007.09.003.
  • Liu, R.; Yu, T.; Shi, Z.; Wang, Z., The Preparation of Metal-Organic Frameworks and Their Biomedical Application. Int. J. Nanomedicine. 2016, 11, 1187–1200. DOI: 10.2147/IJN.S100877.
  • He, L.; Brasino, M.; Mao, C.; Cho, S.; Park, W.; Goodwin, A. P.; Cha, J. N. DNA-Assembled Core-Satellite Upconverting-Metal–Organic Framework Nanoparticle Superstructures for Efficient Photodynamic Therapy. Small. 2017, 13. DOI: 10.1002/smll.201700504.
  • Liu, Y.; Hou, W.; Xia, L.; Cui, C.; Wan, S.; Jiang, Y.; Yang, Y.; Wi, Q.; Qui, L.; Tan, W. ZrMOF Nanoparticles as Quenchers to conjugate DNA Aptamers for Target-Induced Bioimaging and Photodynamic Therapy. Chem. Sci. 2018. DOI: 10.1039/c8sc02210k.
  • Park, J.; Jian, Q.; Feng, D.; Mao, L.; Zhou, H. C., Size-Controlled Synthesis of Porphyrinic Metal–Organic Framework and Functionailzation for Targeted Photodynamic Therapy. J. Am Chem. Soc. 2016, 138, 3518–3525. DOI: 10.1021/jacs.6b00007.
  • Zhang, L.; Lei, J.; Ma, F.; Ling, P.; Lie, J.; Ju, H., A Porphyrin Photosensitized Metal–Organic Framework for Cancer Cell Apoptosis and Caspaseresponsive Theranostics. Chem. Commun. 2015, 51, 10831–10834. DOI: 10.1039/c5cc03028e.
  • Liu, J.; Zhang, L.; Lei, J.; Shen, H.; Ju, X., Multifunctional Metal–Organic Framework Nanoprobe for Cathepsin B‑Activated Cancer Cell Imaging and Chemo-Photodynamic Therapy. ACS Appl Mater Interfaces. 2017, 9, 2150–2158. DOI: 10.1021/acsami.6b14446.
  • Li, S.-Y.; Cheng, H.; Xiw, B.-R.; Qui, W.-X.; Zeng, J.-Y.; Li, C.-X.; Wan, -S.-S.; Zhang, L.; Liu, W.-L.; Zhang, W.-Z., Cancer Cell Membrane Camouflaged Cascade Bioreactor for Cancer Targeted Starvation and Photodynamic Therapy. ACS Nano. 2017, 11, 7006–7018. DOI: 10.1021/acsnano.7b02533.
  • Li, S.-Y.; Cheng, H.; Qui, W.-X.; Zhang, L.; Wan, -S.-S.; Zeng, J.-Y.; Zhang, X.-Z., Cancer Cell Membrane-Coated Biomimetic Platform for Tumor Targeted Photodynamic Therapy and Hypoxia-Amplified Bioreductive Therapy. Biomaterials. 2017, 142, 149–161. DOI: 10.1016/j.biomaterials.2017.07.026.
  • Jia, J.; Zhang, Y.; Zheng, M.; Shan, C.; Yan, H.; Wu, W.; Gao, X.; Cheng, B.; Liu, W.; Tang, Y., Functionalized Eu(III)-Based Nanoscale Metal–Organic Framework to Achieve Near-IR-Triggered and -Targeted Two-Photon Absorption Photodynamic Therapy. Inorg. Chem. 2018, 57, 300–310. DOI: 10.1021/acs.inorgchem.7b02475.
  • Liu, W.; Wang, Y.-M.; Li, Y.-H.; Cai, S.-J.; Yin, X.-B.; He, X.-W.; Zhang, Y.-K. Fluorescent Imaging-Guided Chemotherapy-and-Photodynamic Dual Therapy with Nanoscale Porphyrin Metal–Organic Framework. Small. 2017, 13. DOI: 10.1002/smll.201603459.
  • Cai, H.-J.; Shen, -T.-T.; Zhang, J.; Shan, C.-F.; Jia, J.-G.; Li, X.; Liua, W.-S.; Tang, Y., A Core–Shell metal–Organic-framework(MOF)-based Smart Nanocomposite for efficient NIR/H2O2-responsive Photodynamic Therapy against Hypoxic Tumor Cells. J. Mater. Chem. B. 2017, 5, 2390–2394. DOI: 10.1039/c7tb00314e.
  • Guan, Q.; Zhou, -L.-L.; Li, Y.-A.; Dong, Y.-B., Diiodo-Bodipy-Encapsulated Nanoscale Metal-Organic Framework for pH-Driven Selective and Mitochondria Targetd Photodynamic Therapy. Inorg. Chem. 2018, 57, 10137–10145. DOI: 10.1021/acs.inorgchem.8b01316.
  • Song, M.-R.; Li, D.-Y.; Nian, F.-Y.; Xue, J., .-P.; Chen, -J.-J., Zeolitic Imidazolate Metal Organic Framework-8 as an Efficient pH-controlled Delivery Vehicle for Zincphthalocyanine in Photodynamic Therapy. J. Mater. Sci. 2017, 53, 2351–2361. DOI: 10.1007/s10853-017-1716-z.
  • Liu, J.; Yang, Y.; Zhu, W.; Yi, X.; Dong, Z.; Xu, X.; Chen, M.; Yang, K.; Lu, G.; Jiang, L.; et al., Nanoscale Metal-Organic Frameworks for Combined Photodynamic & Radiation Therapy in Cancer Treatment. Biomaterials. 2016, 97, 1–9. DOI: 10.1016/j.biomaterials.2016.04.034.
  • Lu, K.; He, C.; Guo, N.; Chan, C.; Ni, K.; Weichselbaum, R. R.; Li, W., Chlorin-Based Nanoscale Metal–Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapyand Checkpoint Blockade Immunotherapy. J. Am. Chem. Soc. 2016, 138, 12502–12510. DOI: 10.1021/jacs.6b06663.
  • Chen, R.; Zhang, J.; Chelora, J.; Xiong, Y.; Kershaw, S. V.; Li, K. F.; Lo, P.-K.; Cheah, K. W.; Rogach, A. L.; Zapien, J. A.; et al., Ruthenium(II) Complex Incorporated UiO-67 Metal–Organic Framework Nanoparticles for Enhanced Two-Photon Fluorescence Imaging and Photodynamic Cancer Therapy. ACS Appl. Mater. Interfaces. 2017, 9, 5699–5708. DOI: 10.1021/acsami.6b12469.
  • Kan, J.-L.; Jiang, Y.; Xue, A.; Yu, Y.-H.; Wang, Q.; Zhou, Y.; Dong, Y.-B., Surface Decorated Porphyrinic Nanoscale Metal-Organic Framework for Photodynamic Therapy. Inorg. Chem. 2018, 57, 5420–5428. DOI: 10.1021/acs.inorgchem.8b00384.
  • Zheng, X.; Wang, L.; Pei, Q.; He, S.; Liu, S.; Xie, Z., Metal–Organic Framework@Porous Organic Polymer Nanocomposite for Photodynamic Therapy. Chem. Mater. 2017, 29, 2374–2381. DOI: 10.1021/acs.chemmater.7b00228.
  • Park, J.; Jian, Q.; Feng, D.; Zhou, H. C., Controlled Generation of Singlet Oxygen in Living Cells with Tunable Ratios of the Photochromic Switch in Metal–Organic Frameworks. Angew. Chem. Int. Ed. 2016, 55, 7188–7193. DOI: 10.1002/anie.201602417.
  • Park, J.; Feng, D.; Yuan, S.; Zhou, H.-C., Photochromic Metal-Organic Frameworks: Reversible Control of Singley Oxygen Generation. Angew. Chem. 2015, 127, 440–445. DOI: 10.1002/ange.201408862.
  • Lin, G.; Ding, H.; Chen, R.; Peng, Z.; Wang, B.; Wang, C., 3D Porphyrin-Based Covalent Organic Framework. J. Am Chem. Soc. 2017, 139, 8705–8709. DOI: 10.1021/jacs.7b04141.
  • Zhang, W.; Lu, J.; Gao, X.; Li, P.; Zhang, W.; Ma, Y.; Wang, H.; Tang, B., Enhanced Photodynamic Therapy by Reduced Levels of Intracellular Glutathione Obtained by Employing a Nano-MOF with CuII as the Active Center. Angew. Chem. Int. Ed. Engl. 2018, 57, 4891–4896. DOI: 10.1002/anie.201710800.
  • Lu, K.; He, C.; Lin, W., Nanoscale Metal–Organic Framework for Highly Effective Photodynamic Therapy of Resistant Head and Neck Cancer. J. Am Chem. Soc. 2014, 136, 16712–16715. DOI: 10.1021/ja508679h.
  • Lu, K.; He, C.; Lin, W., A Chlorin-Based Nanoscale Metal–Organic Framework for Photodynamic Therapy of Colon Cancers. J. Am. Chem. Soc. 2015, 137, 7600–7603. DOI: 10.1021/jacs.5b04069.
  • Zhang, Y.; Wang, F.; Liu, C.; Wang, Z.; Kang, L.; Huang, Y.; Dong, K.; Ren, J.; Qu, X., Nanozyme Decorated Metal–Organic Frameworks for Enhanced Photodynamic Therapy. ACS Nano. 2017, 12, 651–661. DOI: 10.1021/acsnano.7b07746.
  • Wang, W.; Wang, L.; Li, Z.; Xie, Z., BODIPY-containing nanoscale Metal-Organic Frameworks for Photodynamic Therapy. Chem. Commun. 2013, 52, 5402–5405. DOI: 10.1039/C6CC01048B.
  • Zhou, -L.-L.; Guan, Q.; L, Y.-A.; Zhou, Y.; Xin, Y.-B.; Dong, Y.-B., One-Pot Synthetic Approach toward Porphyrinatozinc and Heavy-Atom Involved Zr-NMOF and Its Application in Photodynamic Therapy. Inorg. Chem. 2018, 57, 3169–3176. DOI: 10.1021/acs.inorgchem.7b03204.
  • Cheplakova, A. M.; Solovieva, A. O.; Pozmogova, T. N.; Vorotnikov, Y. A.; Brylev, K. A.; Vorotnikova, N. A.; Vorontsova, E. V.; Mironov, Y. V.; Poveschenko, A. F.; Kovalenko, K. A.; et al., Nanosized Mesoporous Metal–Organic Framework MIL-101 as Ananocarrier for Photoactive Hexamolybdenum Cluster Compounds. J. Inorg. Biochem. 2017, 166, 100–107. DOI: 10.1016/j.jinorgbio.2016.11.014.
  • Hu, F.; Mao, D.; Wang, Y.; Wu, W.; Zhao, D.; Kong, D.; Liu, B. Metal–Organic Framework as a Simple and General Inert Nanocarrier for Photosensitizers to Implement Activatable Photodynamic Therapy. Adv. Func. Mater. 2018, 28. DOI: 10.1002/adfm.201707519.
  • Černý, J.; Karásková, M.; Rakušan, J.; Nešpůrek, S., Reactive Oxygen Species Produced by Irradiation of Some Phthalocyanine Derivatives. J. Photochem. Photobiology: Chem. 2010, 210, 82–88. DOI: 10.1016/j.jphotochem.2009.11.016.
  • Hamblin, M. R.; Abrahamse, H., New Photosensitizers for Photodynamic Therapy. Biochem. J. 2016, 473, 347–364. DOI: 10.1042/BJ20150942.
  • Plaetzer, K.; Krammer, B.; Berlanda, J.; Berr, F.; Kiesslich, T., Photophysics and Photochemistry of Photodynamic Therapy: Fundamental Aspects. Lasers Med. Sci. 2009, 24, 259–268. DOI: 10.1007/s10103-008-0539-1.
  • Agostinis, P.; Berg, K.; Cengel, K. A.; Foster, T. H.; Girotti, A. W.; Gollnick, S. O.; Hahn, S. M.; Hamblin, M. R.; Juzeniene, A.; Kessel, D.; et al., Photodynamic Therapy of Cancer: An Update. CA Cancer J. Clin. 2011, 61, 250–281. DOI: 10.3322/caac.20114.
  • Castano, A. P.; Demidova, T. N.; Hamblin, M. R., Mechanisms in Photodynamic Therapy: Part One-Photosensitizers, Photochemistry and Cellular Localization. Photodiagnosis Photodyn. Ther. 2004, 1, 279–293. DOI: 10.1016/S1572-1000(05)00007-4.
  • Urbanski, N. K.; Beresewicz, A. Generation of *OH Initiated by Interaction of Fe2+ and Cu+ with Dioxygen; Comparison with the Fenton Chemistry. Acta Biochimca, Polonic. 2000, 47, 951–962.
  • Lushchak, V. I.;, Classification of Oxidative Stress Based on Its Intensity. Excli J. 2014, 13, 1611–2156. DOI: 10.17877/DE290R-7035.
  • Benov, L.;, Photodynamic Therapy: Current Status and Future Directions. Med. Princp. Pract. 2015, 24, 14–28. DOI: 10.1159/000362416.
  • Mroz, P.; Yaroslavsky, A.; Kharkwa, G. B.; Hamblin, M. R., Cell Death Pathways in Photodynamic Therapy of Cancer. Cancers. 2011, 3, 2516–2539. DOI: 10.3390/cancers3022516.
  • Niedre, M.; Patterson, M. S.; Wilson, B. C., Direct Near-Infrared Luminescence Detection of Singlet Oxygen Generated by Photodynamic Therapy in Cells in Vitro and Tissues in Vivo. J. Photochem. Photobiol. 2002, 75, 382–391. DOI: 10.1562/0031-8655(2002)075<0382:DNILDO>2.0.CO;2.
  • Moan, J.; Berg, K., The Photodegradation of Porphyrins in Cells Can Be Used to Estimate the Lifetime of Singlet Oxygen. J. Photochem. Photobiol. 1991, 53, 549–553. DOI: 10.1111/j.1751-1097.1991.tb03669.x.
  • Poddutoori, P. K.; Bregles, L. P.; Lim, G. N.; Boland, P.; Kerr, R. G.; D’Souza, F., Modulation of Energy Transfer into Sequential Electron Transferupon Axial Coordination of Tetrathiafulvalene in an Aluminum(III)Porphyrin–Free-Base Porphyrin Dyad. Inorg. Chem. 2015, 54, 8482–8494. DOI: 10.1021/acs.inorgchem.5b01190.
  • Abels, C.;, Targeting of the Vascular System of Solid Tumours by Photodynamic Therapy (PDT). Photochem. Photobiol. Sci. 2004, 3, 765–771. DOI: 10.1039/B314241H.
  • Bhuvaneswari, R.; Gan, Y. Y., The Effect of Photodynamic Therapy on Tumor Angiogenesis. Cell. Mol. Life Sci. 2009, 66, 2275–2283. DOI: 10.1007/s00018-009-0016-4.
  • Ferrario, A.; von Tiehl, K. F.; Rucker, N.; Schwarz, M. A.; Gill, P. S.; Gomer, C. J. Antiangiogenic Treatment Enhances Photodynamic Therapy Responsiveness in a Mouse Mammery Carcinoma. Cancer Res. 2000, 60, 4066–4096.
  • Maeding, N.; Verwanger, T.; Krammer, B., Boosting Tumor-Specific Immunity Using PDT. Cancers. 2016, 8, 91–115. DOI: 10.3390/cancers8100091.
  • van Duijinhoven, F. H.; Aalbers, R. I.; Rovers, J. P.; Terpstra, O. T.; Kuppen, P. J., The Immunological Consequences of Photodynamic Treatment of Cancer, a Literature Review. Immunobiology. 2003, 207, 105–113. DOI: 10.1078/0171-2985-00221.
  • Breskey, J. D.; Lacey, S. E.; Vesper, B. J.; Paradise, W. A.; Radosevich, J. A.; Colvard, M. D., Photodynamic Therapy: Occupational Hazards and Preventative Recommendations for Clinical Administration by Healthcare Providers. Photochem. Laser Surg. 2013, 31, 398–407. DOI: 10.1089/pho.2013.3496.
  • Senge, M. O.;, Stirring the Porphyrin Alphabet Soup—Functionalization Reactions for Porphyrins. Chem. Commun. 2011, 47, 1943–1960. DOI: 10.1039/c0cc03984e.
  • Smith, A. M.; Mancini, M. C.; Nie, S., Bioimaging: Second Window for in Vivo Imaging. Nat. Nanotech. 2009, 4, 410–411. DOI: 10.1038/nnano.2009.326.
  • Caliixto, G. M.; Bernegossi, J.; de Freitas, L. M.; Fontana, C. R.; Chlorilli, M., Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review. Molecules. 2016, 21, 342–360. DOI: 10.3390/molecules21030342.
  • Seyfried, T. N.; Huysentruyt, L. C. On the Origin of Cancer Metastasis. Crit, Rev, Oncog. 2013, 18, 43–73.
  • Brown, J. M.;, Tumor Hypoxia in Cancer Therapy. Meth. Enzymol. 2007, 435, 297–321. DOI: 10.1016/S0076-6879(07)35015-5.
  • Haung, Z.; Xu, H.; Meyers, A. D.; Musani, A. I.; Wang, L.; Tagg, R.; Barqawi, A. B.; Chen, Y. K., Photodynamic Therapy for Treatment of Solid Tumors — Potential and Technical Challenges. Technol. Cancer Res. Treat. 2008, 7, 309–320. DOI: 10.1177/153303460800700405.
  • Woodhams, J. H.; Macrobert, A. J.; Bown, S. G., The Role of Oxygen Monitoring during Photodynamic Therapy and Its Potential for Treatment Dosimetry. J. Photochem. Photobiol. 2007, 6, 1246–1256. DOI: 10.1039/b709644e.
  • Woodhams, J. H.; Kunz, L.; Bown, S. G.; MacRobert, A. J., Correlation of Real-Time Haemoglobin Oxygen Saturation Monitoring during Photodynamic Therapy with Microvascular Effects and Tissue Necrosis in Normal Rat Liver. Brit. J. Can. 2004, 91, 788–794. DOI: 10.1038/sj.bjc.6602036.
  • Lucky, S. S.; Soo, K. C.; Zhang, Y., Nanoparticles in Photodynamic Therapy. Chem. Rev. 2014, 115, 1990–2042. DOI: 10.1021/cr5004198.
  • Zhu, T. C.; Finlay, J. C., The Role of Photodynamic Therapy (PDT) Physics. Med. Phys. 2008, 35, 3127–3136. DOI: 10.1118/1.2937440.
  • Looft, A.; Pfitzner, M.; Preuß, A.; Röder, B., In Vivo Singlet Molecular Oxygen Measurements: Sensitive to Changes in Oxygen Saturation during PDT. Photodiagnosis Photodyn. Ther. 2018, 23, 325–330. DOI: 10.1016/j.pdpdt.2018.07.006.
  • Wu, H.; Song, Q.; Ran, G.; Lu, X.; Xu, B., Recent Developments in the Detection of Singlet Oxygen with Molecular Spectroscopic Methods. Trends Analyt. Chem. 2011, 30, 133–141. DOI: 10.1016/j.trac.2010.08.009.
  • Boso, G.; Ke, D.; Korzh, B.; Bouilloux, J.; Lange, N.; Zbinden, H., Time-Resolved Singlet-Oxygen Luminescence Detection with an Efficient and Practical Semiconductor Single-Photon Detector. Biomed. Opt. Express. 2016, 7, 211–224. DOI: 10.1364/BOE.7.000211.
  • Gemmel, N. R.; McCarthy, A.; Liu, B.; Tanner, M. G.; Dorenbos, S. D.; Zwiller, V.; Patterson, M. S.; Buller, G. S.; Wilson, B.; Hadfeild, R. H., Singlet Oxygen Luminescence Detection with a Fiber-Coupled Superconducting Nanowire Single-Photon Detector. Opt. Express. 2013, 21, 5005–5013. DOI: 10.1364/OE.21.005005.
  • Finlay, J. C.; Conover, D. L.; Hull, E. L.; Foster, T. H., Porphyrin Bleaching and PDT-induced Spectral Changes are Irradiance Dependent in ALA-sensitized Normal Rat Skin in Vivo. J. Photochem. Photobiol. 2001, 73, 54–63. DOI: 10.1562/0031-8655(2001)073<0054:PBAPIS>2.0.CO;2.
  • Giovannetti, R.;. The Use of Spectrophotometry UV-Vis for the Study of Porphyrins. In Macro to Nano Spectroscopy, Jamal Uddin, InTechOpen: London, 2012; pp 87–108.
  • Rio, Y.; Rodriguez-Morgade, S.; Torres, T., Modulating the Electronic Properties of Porphyrinoids: A Voyage from the Violet to the Infrared Regions of the Electromagnetic Spectrum. Org. Biomol. Chem. 2008, 6, 1877–1894. DOI: 10.1039/b800617b.
  • Huang, Z.;, A Review of Progress in Clinical Photodynamic Therapy. Technol. Cancer Res. Treat. 2005, 4, 283–293. DOI: 10.1177/153303460500400308.
  • Josefsen, L. B.; Boyle, R. W. Photodynamic Therapy and the Development of Metal-Based Photosensitisers. Met. Based. Drugs. 2008, 4. DOI: 10.1155/2008/276109.
  • Detty, M. R.; Gibson, S. L.; Wagner, S. J., Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy. J. Med. Chem. 2004, 47, 3897–3915. DOI: 10.1021/jm040074b.
  • Garcia, G.; Hammerer, F.; Poyer, F.; Achelle, S.; Teulade-Fichou, M.-P.; Maillard, P., Carbohydrate-Conjugated Porphyrin Dimers: Synthesis and Photobiological evaluation for a Potential Application in One-Photon and Two-Photonphotodynamic Therapy. Bioorg. Med. Chem. 2013, 21, 153–156. DOI: 10.1016/j.bmc.2012.10.042.
  • Furuyama, T.; Satoh, K.; Kushiya, T.; Kobayashi, N., Design, Synthesis, and Properties of Phthalocyanine Complexes with Main-Group Elements Showing Main Absorption and Fluorescencebeyond 1000 Nm. J. Am Chem. Soc. 2013, 136, 765–776. DOI: 10.1021/ja411016f|.
  • Cramers, P.; Ruevekamp, M.; Oppelaar, O.; Baas, P.; Stewart, F. A., Foscan® Uptake and Tissue Distribution in Relation to Photodynamic Efficacy. Brit. J. Can. 2003, 88, 283–290. DOI: 10.1038/sj.bjc.6600682.
  • Senge, M. O.; Brandt, J. C., Temoporfin (Foscan®, 5,10,15,20-Tetra(M-Hydroxyphenyl)Chlorin)–A Second-Generation Photosensitizer. J. Photochem. Photobiol. 2011, 87, 1240–1296. DOI: 10.1111/j.1751-1097.2011.00986.x.
  • Hudson, R.; Carcenac, M.; Smith, K. A.; Boyle, R. W., The Development and Characterisation of Porphyrin Isothiocyanate-Monoclonal Antibody Conjugates for Photoimmunotherapy. Brit. J. Can. 2005, 92, 1442–1449. DOI: 10.1038/sj.bjc.6602517.
  • Staneloudi, C.; Smith, K. A.; Hudson, R.; Maletesti, N.; Savoie, H.; Boyle, R.; Greenman, J., Development and Characterization of Novel Photosensitizer: ScFv Conjugates for Use in Photodynamic Therapy of Cancer. J. Immunol. 2007, 120, 512–517. DOI: 10.1111/j.1365-2567.2006.02522.x.
  • Kaščáková, S.; Hofland, L. J.; De Bruijin, H. S.; Ye, Y.; Achilefu, S.; van der Wansem, K.; Ploeg-van Den Heuvel, A.; van Koetsveld, P. M.; Brugts, M. P.; van der Lelij, A.; et al. Somatostatin Analogues for Receptor Targeted Photodynamic Therapy. PLOS ONE. 2014, 9. DOI: 10.1371/journal.pone.0104448.
  • Kataoka, H.; Nishie, H.; Hayashi, N.; Tanaka, M.; Nomoto, A.; Yano, S.; Joh, T., New Photodynamic Therapy with Next-Generation Photosensitizers. Ann. Transl Med. 2017, 5, 183. DOI: 10.21037/atm.2017.03.59.
  • Hayashi, N.; Kataoka, H.; Yano, S.; Tanaka, M.; Moriwaki, K.; Akashi, H.; Suzuki, S.; Mori, Y.; Kubota, E.; Tanida, S.; et al., A Novel Photodynamic Therapy Targeting Cancer Cells and Tumor-Associated Macrophages. Mol. Cancer Ther. 2014, 14, 452–460. DOI: 10.1158/1535-7163.MCT-14-0348.
  • Ol’shevskay, V. A.; Nikitina, R. G.; Savchenko, A. N.; Malshakova, M. V.; Vinogradov, A. M.; Golovina, G. V.; Belykh, D. V.; Kutchin, A. V.; Kaplan, M. A.; Kalinin, V. N.; et al., Novel Boronated Chlorin E6-Based Photosensitizers: Synthesis, Bindingto Albumin and Antitumour Efficacy. Bioorg. Med. Chem. 2009, 17, 1297–1306. DOI: 10.1021/jm011010t.
  • Lovell, J. F.; Jin, C. S.; Huynh, E.; Jin, H.; Kim, C.; Rubinstein, J. L.; Chan, W. C. W.; Cao, W.; Wang, L. V.; Zheng, G. Porphysome Nanovesicles Generated by Porphyrin Bilayers for Use as Multimodal Biophotonic Contrast Agents. Nat. Mater. 2011, 10, 324. DOI: 10.1038/nmat2986.
  • Liu, K.; Xing, R.; Zou, Q.; Ma, G.; Möhwald, H.; Yan, X. Simple Peptide-Tuned Self-Assembly of Photosensitizers Towards Anticancer Photodynamic Therapy. Angewandte Chemie. 2016, 55(9), 3036–3039. DOI: doi:10.1002/anie.201509810.
  • Zhang, N.; Zhao, F.; Zou, Q.; Li, Y.; Ma, G.; Yan, X. Drug Delivery: Multitriggered Tumor-Responsive Drug Delivery Vehicles Based on Protein and Polypeptide Coassembly for Enhanced Photodynamic Tumor Ablation (Small 43/2016). Small. 2016, 12(43), 5935. DOI: doi:10.1002/smll.201670224.
  • Yang, X.; Fei, J.; Li, Q.; Li, J. Covalently Assembled Dipeptide Nanospheres as Intrinsic Photosensitizers for Efficient Photodynamic Therapy in Vitro. Chem. Eur. J. 2016, 22(19), 6477–6481. DOI: doi:10.1002/chem.201600536.
  • Allison, R. R.; Bagnato, V. S.; Sibata, C. H., Future of Oncologic Photodynamic Therapy. Future Oncol. 2010, 6, 929–940. DOI: 10.2217/fon.10.51.
  • Chatterjee, D. K.; Fong, L. S.; Zhang, Y., Nanoparticles in Photodynamic Therapy: An Emerging Paradigm. Adv. Drug Deliv. Rev. 2008, 60, 1627–1637. DOI: 10.1016/j.addr.2008.08.003.
  • Wicki, A.; Witzigmann, D.; Balasubramanian, V.; Huwyler, J., Nanomedicine in Cancer Therapy: Challenges, Opportunities, and Clinical Applications. J. Controlled Release. 2015, 200, 138–157. DOI: 10.1016/j.jconrel.2014.12.030.
  • Bechet, D.; Coulaud, P.; Frochot, C.; Viriot, M. L.; Guillemin, F.; Barberi-Hyob, M., Nanoparticles as Vehicles for Delivery of Photodynamic Therapy Agents. Trends Biotechnol. 2008, 26, 612–621. DOI: 10.1016/j.tibtech.2008.07.007.
  • Jain, K. K.;, Recent Advances in Nanooncology. Technol. Cancer Res. Treat. 2008, 7, 1–13. DOI: 10.1177/153303460800700101.
  • Obaid, G.; Broekgaarden, M.; Bulin, A.; Huang, H.; Kuriakose, J.; Hasan, T., Photonanomedicine: A Convergence of Photodynamic Therapy and Nanotechnology. Nanoscale. 2016, 8, 12471–12503. DOI: 10.1039/c5nr08691d.
  • Huang, K. K.; Sharma, S. K.; Dai, T.; Chung, H.; Yaroslavsky, A.; Garcia-Diaz, M.; Chang, J.; Chiang, L. Y.; Hamblin, M. R., Can Nanotechnology Potentiate Photodynamic Therapy. Nanotechnol. Rev. 2012, 1, 111–146. DOI: 10.1515/ntrev-2011-0005.
  • Chen, G.; Roy, I.; Yang, C.; Prasad, P. N., Nanochemistry and Nanomedicine for Nanoparticle-Based Diagnostics and Therapy. Chem. Rev. 2016, 116, 2826. DOI: 10.1021/acs.chemrev.5b00148.
  • Chouikrat, R.; Seve, A.; Vanderesse, R.; Benachour, H.; Barberi-Heyob, M.; Richeter, S.; Raehm, L.; Durang, J. O.; Verelst, M.; Frochot, C., Non Polymeric Nanoparticles for Photodynamic Therapy Applications: Recent Developments. Curr. Med. Chem. 2012, 19, 781–792. DOI: 10.2174/092986712799034897.
  • Yin, Z. F.; Wu, L.; Yang, H. G.; Su, Y. H., Recent Progress in Biomedical Applications of Titanium Dioxide. Phys. Chem. Chem. Phys. 2013, 15, 4844–4858. DOI: 10.1039/C3CP43938K.
  • Juzenas, P.; Chen, W.; Sun, Y. P.; Coelho, M. A.; Generalov, R.; Generalova, N.; Christensen, I. L., Quantum Dots and Nanoparticles for Photodynamic and Radiation Therapies of Cancer. Adv. Drug Deliv. Rev. 2008, 60, 1600–1614. DOI: 10.1016/j.addr.2008.08.004.
  • Shibu, E. S.; Hamada, M.; Murase, N.; Biju, V., Nanomaterials Formulations for Photothermal and Photodynamic Therapy of Cancer. J. Photochem. Photobiol. C. 2013, 15, 53–72. DOI: 10.1016/j.jphotochemrev.2012.09.004.
  • Rasmussen, J. W.; Martinez, E.; Louka, P.; Wingett, D. G. Zinc Oxide Nanoparticles for Selective Destruction of Tumor Cells and Potential for Drug Delivery Applications. Expert. Opin. Drug Deliv. 2010, 9, 1063–1077. DOI: 10.1517/17425247.2010.502560.
  • Matsumura, Y. M. H. A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs. Cancer Res. 1986, 46, 6387–6392.
  • Liu, D.; Mori, A.; Huang, L., Role of Liposome Size and RES Blockade in Controlling Biodistribution and Tumor Uptake of GM1-containing Liposomes. Biochim. Biophys. Acta. 1992, 1104, 95–101. DOI: 10.1016/0005-2736(92)90136-A.
  • Thandu, M.; Rapozzi, V.; Xodo, L.; Albericio, F.; Comuzzi, C.; Cavalli, S., “Clicking” Porphyrins to Magnetic Nanoparticles for Phtodynamic Therpay. ChemPlusChem. 2013, 79, 90–98. DOI: 10.1002/cplu.201300276.
  • Witjes, A.; Douglass, J., The Role of Hexaminolevulinate Fluorescence Cystoscopy in Bladder Cancer. Nat. Clin. Pract. Urol. 2007, 4, 542–549. DOI: 10.1038/ncpuro0917.
  • Krieg, R. C.; Messmann, H.; Rauch, J.; Seeger, S.; Knuechel, R., Metabolic Characterization of Tumor Cell-Specific Protoporphyrin IX Accumulation after Exposure to 5-Aminolevulinic Acid in Human Colonic Cells. J. Photochem. Photobiol. 2002, 76, 518–525. DOI: 10.1562/0031-8655(2002)0760518MCOTCS2.0.CO2.
  • D’Cruz, A. K.; Robinson, M. H.; Biel, M. A., Mthpc-Mediated Photodynamic Therapy in Patients with Advanced, Incurable Head and Neck Cancer: A Multicenter Study of 128 Patients. Head and Neck. 2004, 26, 232–240. DOI: 10.1002/hed.10372.
  • Wolfsen, H. C.; Hemminger, L. L.; Wallace, M. B.; Devault, K. R., Clinical Experience of Patients Undergoing Photodynamic Therapy for Barrett’s Dysplasia or Cancer. Aliment. Pharmacol. Ther. 2004, 20, 1125–1131. DOI: 10.1111/j.1365-2036.2004.02209.x.
  • Corti, L.; Skarlatos, J.; Boso, C.; Cardin, F.; Kosma, L.; Koukourakis, M. I.; Giatromanolaki, A.; Norberto, L.; Shaffer, M.; Beroukas, K., Outcome of Patients Receiving Photodynamic Therapy for Early Esophageal Cancer. Int. J. Radiat. Oncol. Biol. Phys. 2000, 47, 419–424. DOI: 10.1016/S0360-3016(00)00450-8.
  • Trachtenberg, J.; Weersink, R. A.; Davidson, S. R.; Haider, M. A.; Bogaards, A.; Gertner, M. R.; Evans, A.; Scherz, A.; Savard, J.; Chin, J. L.; et al., Vascular-Targeted Photodynamic Therapy (Padoporfin, WST09) for Recurrent Prostate Cancer after Failure of External Beam Radiotherapy: A Study of Escalating Light Doses. BJU Int. 2008, 102, 556–562. DOI: 10.1111/j.1464-410X.2008.07753.x.
  • Furuse, L.; Fukuoka, M.; Kato, H.; Horai, T.; Kubota, K.; Kodama, N.; Kusunkoi, Y.; Takifuji, N.; Okunaka, T.; Konaka, C. J., A Prospective Phase II Study on Photodynamic Therapy with Photofrin II for Centrally Located Early-Stage Lung Cancer. J. Clin. Oncol. 1993, 11, 1852–1857. DOI: 10.1200/JCO.1993.11.10.1852.
  • Yaghi, O. M.; Li, H., Hydrothermal Synthesis of a Metal-Organic Framework Containing Large Rectangular Channels. J. Am Chem. Soc. 1995, 117, 10401–10402. DOI: 10.1021/ja00146a033.
  • Li, H.; Eddaoudi, M.; O’Keeffe, M.; Yaghi, O. M., Design and Synthesis of an Exceptionally Stable and Highly Porous Metal-Organic Framework. Nature. 1995, 402, 276–277. DOI: 10.1038/46248.
  • Farha, O. K.; Eryazici, I.; Jeong, N. C.; Hauser, B. G.; Wilmer, C. E.; Sarjeant, A. A.; Snurr, R. Q.; Nguyen, S. T.; Yazaydin, A. O.; Hupp, J. T., Metal–Organic Framework Materials with Ultrahigh Surface Areas: Is the Sky the Limit?. J. Am Chem. Soc. 2012, 134, 15016–15021. DOI: 10.1021/ja3055639.
  • Moghadam, P. Z.; Li, A.; Wiggin, S. B.; Tao, A.; Maloney, A. G. P.; Wood, P. A.; Ward, S. C.; Fairen-Jimenez, D. Development of A Cambridge Structural Database Subset: A Collection of Metal–Organic Frameworks for Past, Present, and Future. Chem. Mater. 2017, 2618–2652. DOI: 10.1021/acs.chemmater.7b00441.
  • Doonan, C. J.; Morris, W.; Furukawa, H.; Yaghi, O. M., Isoreticular Metalation of Metal–Organic Frameworks. J. Am Chem. Soc. 2009, 131, 9492–9493. DOI: 10.1021/ja903251e.
  • Eddaudi, M.; Kim, J.; Rosi, N.; Vodak, D.; Wachter, J.; O’Keeffe, M.; Yaghi, O. M., Systematic Design of Pore Size and Functionality in Isoreticular MOFs and Their Application in Methane Storage. sci. 2002, 295, 469–472. DOI: 10.1126/science.1067208.
  • Huang, H.; Li, J. R.; Wang, K.; Han, T.; Tong, M.; Li, L.; Xie, Y.; Yang, Q.; Liu, D.; Zhong, C. An in Situ Self-Assembly Template Strategy for the Preparation of Hierarchical-Pore Metal-Organic Frameworks. Nat, Commun. 2015, 6. DOI: 10.1038/ncomms9847.
  • Katz, M. J.; Brown, Z. J.; Colón, Y. J.; Siu, P. W.; Scheidt, K. A.; Snurr, R. Q.; Hupp, J. T.; Farha, O. K., A Facil Synthesis of UiO-66, UiO-67 and Their Derivatives. Chem. Commun. 2013, 49, 9499. DOI: 10.1039/C3CC46105J.
  • Allendorg, M. D.; Stavila, V., Crystal Engineering, Structure–Function Relationships, and the Future of Metal–Organic Frameworks. Cryst. Eng. Comm. 2014, 17, 229–246. DOI: 10.1039/C4CE01693A.
  • Seoane, B.; Castellanos, S.; Dikhtiarenko, A.; Kapteijn, F.; Gascon, J., Multi-Scale Crystal Engineering of Metal Organic Frameworks. Coord. Chem. Rev. 2016, 307, 147–187. DOI: 10.1016/j.ccr.2015.06.008.
  • Li, J. R.; Kuppler, R. J.; Zhou, H. C., Selective Gas Adsorption and Separation in Metal–Organic Frameworks. Chem. Soc. Rev. 2009, 38, 1477–1504. DOI: 10.1039/B802426J.
  • Farha, O. K.; Özgür Yazaydın, A.; Eryazici, I.; Malliakas, C. D.; Hauser, B. G.; Kanatzidis, M. G.; Nguyen, S. T.; Snurr, R. Q.; Hupp, J. T., De Novo Synthesis of a Metal–Organic Framework Material Featuring Ultrahigh Surface Area and Gas Storage Capacities. Nat. Chem. 2010, 2, 944–948. DOI: 10.1021/ja3055639.
  • Tan, K.; Zuluaga, S.; Fuentes, E.; Mattson, E. C.; Veyan, J. F.; Wang, H.; Li, J.; Thonhauser, T.; Chabal, Y. J., Trapping Gases in Metal-Organic Frameworks with a Selective Surface Molecular Barrier Layer. Nat, Commun. 2016, 7, 13871. DOI: 10.1038/ncomms13871.
  • Huang, Y. B.; Liang, J.; Wang, X. S.; Cao, R., Multifunctional Metal–Organic Framework Catalysts: Synergistic Catalysis and Tandem Reactions. Chem. Soc. Rev. 2016, 46, 126–157. DOI: 10.1039/c6cs00250a.
  • Beyzavi, M. H.; Vermeulen, N. A.; Howarth, A. J.; Tussupbayev, S.; League, A. B.; Schweitzer, N. M.; Gallagher, J. R.; Platero-Prats, A. E.; Hafezi, N.; Sargeant, A. A.; et al., A Hafnium-Based Metal–Organic Framework as A Nature-Inspired Tandem Reaction Catalyst. J. Am Chem. Soc. 2015, 137, 13624–13631. DOI: 10.1021/jacs.5b08440.
  • Liu, H.; Xi, F. G.; Sun, W.; Yang, N. N.; Gao, E. Q., Amino- and Sulfo-Bifunctionalized Metal–Organic Frameworks: One-Pot Tandem Catalysis and the Catalytic Sites. Inorg. Chem. 2016, 55, 5753–5755. DOI: 10.1021/acs.inorgchem.6b01057.
  • Shekak, O.; Liu, J.; Fischer, R. A.; Wöll, C., MOF Thin Films: Existing and Future Applications. Chem. Soc. Rev. 2011, 40, 1081–1106. DOI: 10.1039/C0CS00147C.
  • Gliemann, H.; Wöll, C., Epitaxially Grown Metal-Organic Frameworks. Mater. Today Chem. 2012, 15, 110–116. DOI: 10.1016/S1369-7021(12)70046-9.
  • Virmani, E.; Rotter, J. M.; Mähringer, A.; von Zons, T.; Godt, A.; Bein, T.; Wuttke, S.; Medina, D. D., On-Surface Synthesis of Highly Oriented Thin Metal-Organic Framework Films through Vapor-Assisted Conversion. J. Am Chem. Soc. 2018, 140, 4812–4819. DOI: 10.1021/jacs.7b08174.
  • Tan, K.; Nijem, N.; Canepa, P.; Gong, Q.; Li, J.; Thonhauser, T.; Chabal, Y. J., Stability and Hydrolyzation of Metal Organic Frameworks with Paddle-Wheel SBUs upon Hydration. Chem. Mater. 2012, 24, 3153–3167. DOI: 10.1021/cm301427w.
  • King, S. C.; Wang, H.; Arman, H. D.; Chen, B., A Two-Dimensional Metal-Organic Framework Composed of Paddle-Wheel Cobalt Clusters with Permanent Porosity. Inorg. Chem. Commun. 2016, 74, 98–101. DOI: 10.1016/j.inoche.2016.11.004.
  • Lee, J.; Kwak, J. H.; Choe, W. Evolution of Form in Metal–Organic Frameworks. Nat. Comm. 2017, 8. DOI: 10.1038/ncomms14070.
  • Yuan, S.; Qin, J. S.; Lollar, C. T.; Zhou, H. C., Stable Metal–Organic Frameworks with Group 4 Metals: Current Status and Trends. ACS Cent. Sci. 2018, 4, 440–450. DOI: 10.1021/acscentsci.8b00073.
  • Burtch, N. C.; Jasuja, H.; Walton, K. S., Water Stability and Adsorption in Metal–Organic Frameworks. Chem. Rev. 2014, 114, 10575–10612. DOI: 10.1021/cr5002589.
  • Bosch, M.; Zhang, M.; Zhou, H. C., Increasing the Stability of Metal-Organic Frameworks. Adv. Chem. 2014, 2014, 8. DOI: 10.1155/2014/182327.
  • Cavka, J. H.; Jakobsen, S.; Olsbye, U.; Guillou, N.; Lambert, C.; Bordiga, S.; Lillerud, K. P., A New Zirconium Inorganic Building Brick Forming Metal Organic Frameworks with Exceptional Stability. J. Am. Chem. Soc. 2008, 130, 13850–13851. DOI: 10.1021/ja8057953.
  • Chen, T. H.; Popoz, I.; Kaveevivitchai, W.; Miljani, O. S., Metal–Organic Frameworks: Rise of the Ligands. Chem. Mater. 2014, 26, 4322–4325. DOI: 10.1021/cm501657d.
  • Lu, W.; Wei, Z.; Gu, Z. Y.; Liu, T. F.; Park, J.; Park, J.; Tian, J.; Zhang, M.; Zhang, Q.; Gentle, T.; et al., Tuning the Structure and Function of Metal–Organic Frameworks via Linker Design. Chem. Soc. Rev. 2014, 43, 5561–5593. DOI: 10.1039/c4cs00003j.
  • Forgan, R. S.; Smaldone, R. A.; Gassensmith, J. J.; Furukawai, H.; Cordes, D. B.; Li, Q.; Wilmer, C. E.; Botros, Y. Y.; Snurr, R. Q.; Slawin, A. M. Z.; et al., Nanoporous Carbohydrate Metal–Organic Frameworks. J. Am Chem. Soc. 2012, 134, 406–417. DOI: 10.1021/ja208224f.
  • Kosal, M. E.; Chou, J.-H.; Wilson, S. R.; Suslick, K. S., A Functional Zeolite Analogue Assembled from Metalloporphyrins. Nat. Mater. 2002, 1, 118–121. DOI: 10.1038/nmat730.
  • Zou, C.; Wu, C.-D., Functional Porphyrinic Metal–Organic Frameworks: Crystal Engineering and Applications. Dalton Trans. 2011, 41, 3879–3888. DOI: 10.1039/c2dt11989g.
  • Huh, S.; Kim, S. J.; Kim, Y., Porphyrinic Metal–Organic Frameworks from Custom-Designed Porphyrins. Cryst. Eng. Comm. 2015, 18, 345–368. DOI: 10.1039/C5CE02106E.
  • Lee, J.; Farha, O. K.; Roberts, J.; Scheidt, K. A.; Nguyen, S. T.; Hupp, J. T., Metal–Organic Framework Materials as Catalysts. Chem. Soc. Rev. 2009, 38, 1450–1459. DOI: 10.1039/b807080f.
  • Zhao, M.; Ou, S.; Wu, C.-D., Porous Metal-Organic Frameworks for Heterogeneous Biomimetic Catalysis. Acc. Chem. Res. 2014, 47, 1199–1207. DOI: 10.1021/ar400265x.
  • Nakagaki, S.; Ferreira, G. K. B.; Ucoski, G. M.; Freitas Castro, K. A. D., Chemical Reactions Catalyzed by Metalloporphyrin-Based Metal-Organic Frameworks. Molecules. 2013, 18, 7279–7308. DOI: 10.3390/molecules18067279.
  • Lee, C. Y.; Farha, O. K.; Hong, B. J.; Sarjeant, A. A.; Nguyen, S. T.; Hupp, J. T., Light-Harvesting Metal–Organic Frameworks (Mofs): Efficient Strut-to-Strut Energy Transfer in Bodipy and Porphyrin-Based MOFs. J. Am. Chem. Soc. 2011, 133, 15858–15861. DOI: 10.1021/ja206029a.
  • Kent, C. A.; Liu, D.; Ma, L.; Papanikolas, J. M.; Meyer, T. J.; Lin, W., Light Harvesting in Microscale Metal–Organic Frameworks by Energy Migration and Interfacial Electron Transfer Quenching. J. Am. Chem. Soc. 2011, 133, 12940–12943. DOI: 10.1021/ja204214t.
  • Son, H. J.; Jin, S.; Patwardhan, S.; Wezenberg, S. J.; Jeong, N. C.; So, M.; Wilmer, C. E.; Sarjeant, A. A.; Schatz, G. C.; Snurr, R. Q.; et al., Light-Harvesting and Ultrafast Energy Migration in Porphyrin-Based Metal–Organic Frameworks. J. Am. Chem. Soc. 2013, 135, 862–869. DOI: 10.1021/ja310596a.
  • Wang, Z.; Cohen, S. M., Modulating Metal-Organic Frameworks to Breathe: A Postsynthetic Covalent Modification Approach. J. Am. Chem. Soc. 2009, 131, 16675–16677. DOI: 10.1021/ja907742z.
  • Sun, X.; Guo, X.; Zhang, Z. Y.; Qiu, S.; Su, X., Versatile Tailoring of NH2‐Containing Metal–Organic Frameworks with Paddle-Wheel Units. Chem. Eur. J. 2017, 23, 17727–17733. DOI: 10.1002/chem.201703126.
  • Burrows, A. D.; Frost, C. G.; Mahon, M. F.; Richardson, C., Post-Synthetic Modification of Tagged Metal–Organic Frameworks. Angew. Chem. Int. Ed. 2008, 120, 8610–8614. DOI: 10.1002/ange.200802908.
  • Tanabe, K. K.; Cohen, S. M., Postsynthetic Modification of Metal–Organic Frameworks—A Progress Report. Chem. Soc. Rev. 2010, 40, 498–519. DOI: 10.1039/c0cs00031k.
  • Lalonde, M.; Bury, W.; Karagiaridi, O.; Brown, Z.; Hupp, J. T.; Farha, O. K., Transmetalation: Routes to Metal Exchange within Metal–Organic Frameworks. J. Mater. Chem. A. 2013, 1, 5453–5468. DOI: 10.1039/C3TA10784A.
  • Kahr, J.; Morris, R. E.; Wright, P. A., Post-Synthetic Incorporation of Nickel into CPO-27(Mg) to Give Materials with Enhanced Permanent Porosity. Cryst. Eng. Comm. 2013, 15, 9779–9786. DOI: 10.1039/C3CE41228H.
  • Klet, R. C.; Wang, T. C.; Fernandez, L. E.; Truhlar, D. G.; Hupp, J. T.; Farha, O. K., Synthetic Access to Atomically Dispersed Metals in Metal–Organic Frameworks via a Combined Atomic-Layer-Deposition-In-MOF and Metal-Exchange Approach. Chem. Mater. 2016, 28, 1213–1219. DOI: 10.1021/acs.chemmater.5b04887.
  • Kim, M.; Cahill, J. F.; Fei, H.; Prather, K. A.; Cohen, S. M., Postsynthetic Ligand and Cation Exchange in Robust Metal–Organic Frameworks. J. Am. Chem. Soc. 2012, 134, 18082–18088. DOI: 10.1021/ja3079219.
  • Deria, P.; Bury, W.; Hod, I.; Kung, C. W.; Karagiaridi, O.; Hupp, J. T.; Farha, O. K., MOF Functionalization via Solvent-Assisted Ligand Incorporation: Phosphonates Vs Carboxylates. Inorg. Chem. 2015, 54, 2185–2192. DOI: 10.1021/ic502639v.
  • Lalonde, M. B.; Mondloch, J. E.; Deria, P.; Sarjeant, A. A.; Juaid, S. S.; Osman, O. I.; Farha, O. K.; Hupp, J. T., Selective Solvent-Assisted Linker Exchange (SALE) in a Series of Zeolitic Imidazolate Frameworks. Inorg. Chem. 2015, 54, 7142–7144. DOI: 10.1021/acs.inorgchem.5b01231.
  • Yuan, S.; Chen, Y. P.; Qin, J.; Lu, W.; Wang, X.; Zhang, Q.; Bosch, M.; Liu, T.-F.; Lian, X.; Zhou, H.-C., Cooperative Cluster Metalation and Ligand Migration in Zirconium Metal–Organic Frameworks. Andew. Chem. 2015, 127, 14909–14913. DOI: 10.1002/ange.201505625.
  • Della Rocca, J.; Liu, D.; Lin, W., Nanoscale Metal Organic Frameworks for Biomedical Imaging and Drug Delivery. Acc. Chem. Res. 2011, 44, 957–968. DOI: 10.1021/ar200028a.
  • Xu, R.; Wang, Y.; Duan, X.; Lu, K.; Micheroni, D.; Hu, A.; Lin, W., Nanoscale Metal–Organic Frameworks for Ratiometric Oxygen Sensing in Live Cells. J. Am Chem. Soc. 2016, 138, 2158–2161. DOI: 10.1021/jacs.5b13458.
  • Taylor, K. M. L.; Rieter, W. J.; Lin, W. Manganese-Based Nanoscale Metal–Organic Frameworks for Magnetic Resonance Imaging. J. Am Chem. Soc. 2008, 130, 14358–14359. 0.1021/ja803777x.
  • Zhang, Y.; Liu, C.; Wang, F.; Liu, Z.; Ren, J.; Qu, X., Metal–Organic-Framework-Supported Immunostimulatory Oligonucleotides for Enhanced Immune Response and Imaging. Chem. Commun. 2017, 53, 1840–1843. DOI: 10.1039/C6CC09280B.
  • Wang, L.; Zheng, M.; Xie, Z., Nanoscale Metal-Organic Frameworks for Drug Delivery: A Conventional Platform with New Promise. J. Mater. Chem. B. 2017, 6, 707–717. DOI: 10.1039/C7TB02970E.
  • Ibrahim, M.; Sabouni, R.; Husseine, G. A., Anti-Cancer Drug Delivery Using Metal Organic Frameworks (Mofs). Curr. Med. Chem. 2017, 24, 193–214. DOI: 10.2174/0929867323666160926151216.
  • Horcajada, P.; Chalati, T.; Serre, C.; Gillet, B.; Sebrie, C.; Baati, T.; Eurbank, J. F.; Heurtaux, D.; Clayette, P.; Kreuz, C.; et al., Porous Metal-Organic-Framework Nanoscale Carriers as a Potential Platform for Drug Delivery and Imaging. Nat. Mater. 2010, 9, 172–178. DOI: 10.1038/nmat2608.
  • Carné, A.; Carbonell, C.; Imaz, I.; Maspoch, D., Nanoscal Metal-Organic Materials. Chem. Soc. Rev. 2011, 40, 291–305. DOI: 10.1039/C0CS00042F.
  • Wang, X.-G.; Cheng, Q.; Yu, Y.; Zhang, X.-Z., Controlled Nucleation and Controlled Growth for Size Predicable Synthesis of Nanoscale Metal-Organic Frameworks (Mofs): A General and Scalable Approach. Angew. Chem. 2018, 130, 7836–7840. DOI: 10.1002/anie.201803766.
  • Kim, S.; Ohulchanskyy, T. Y.; Bharali, D.; Chen, Y.; Pandey, R.; Prasad, P. N., Organically Modified Silica Nanoparticles with Intraparticle Heavy-Atom Effect on the Encapsulated Photosensitizer for Enhanced Efficacy of Photodynamic Therapy. J. Phys. Chem. C. 2009, 113, 12641–12644. DOI: 10.1021/jp900573s.
  • Birks, J. B.;. Photophysics of Aromatic Molecules. Wilcy. 1970, 4, 704.
  • Gorman, A.; Killoran, J.; O’Shea, C.; Kenna, T.; Gallagher, W. M.; O’Shea, D. F., In Vitro Demonstration of the Heavy-Atom Effect for Photodynamic Therapy. J. Am Chem. Soc. 2004, 126, 10619–10631. DOI: 10.1021/ja047649e.
  • Valeur, B.;. Molecular Fluorescence: Principles and Applications, Wiley: Weinheim, 2001.
  • Horcajada, P.; Gref, R.; Baati, T.; Allan, P. K.; Maurin, G.; Couvreur, P.; Ferey, G.; Morris, R. E.; Serre, C., Metal Organic Frameworks in Biomedicine. Chem. Rev. 2012, 112, 1232–1268. DOI: 10.1021/cr200256v.
  • Zwicke, G. L.; Mansoori, G. A.; Jeffery, C. J. Utilizing the Folate Receptor for Active Targeting of Cancer Nanotherapeutics. Nano. Rev. 2012, 3. DOI: 10.3402/nano.v3i0.18496.
  • Xia, W.; Low, P. S., Folate-Targeted Therapies for Cancer. J. Med. Chem. 2010, 53, 6811–6824. DOI: 10.1021/jm100509v.
  • Tranchemontagne, D. J.; Hunt, J. R.; Yaghi, O. M., Room Temperature Synthesis of Metal-Organic Frameworks: MOF-5, MOF-74, MOF-177, MOF-199, and IRMOF-0. Tetrahedron. 2008, 64, 8553–8557. DOI: 10.1016/j.tet.2008.06.036.
  • Bauer, S.; Serre, C.; Devic, T.; Horcajada, P.; Marrot, J.; Férey, G.; Stock, N., High-Throughput Assisted Rationalization of the Formation of Metal Organic Frameworks in the Iron(III) Aminoterephthalate Solvothermal System. Inorg. Chem. 2008, 47, 7568–7576. DOI: 10.1021/ic800538r.
  • Feng, D.; Chung, W. C.; Wei, Z.; Gu, Z. Y.; Jiang, H. L.; Chen, Y. P.; Darensbourg, D. J.; Zhou, H. C., Construction of Ultrastable Porphyrin Zr Metal–Organic Frameworks through Linker Elimination. J. Am Chem. Soc. 2013, 135, 17105–17110. DOI: 10.1021/ja408084j.
  • Reddy, S. B.; Williamson, S. K., Tirapazamine: A Novel Agent Targeting Hypoxic Tumor Cells. Expert. Opin. Drug Deliv. 2009, 18, 77–87. DOI: 10.1517/13543780802567250.
  • Probodh, I.; Cramb, D. T. Two-Photon Excitation Photodynamic Therapy: Working toward a New Treatment for Wet Age-Related Macular Degeneration. In Age Related Macular Degeneration; Y, G.-S., Ed.; IntechOpen: London, 2012; pp 213–226.
  • Starkey, J. R.; Rebane, A. K.; Drobizhev, M. A.; Meng, F.; Gong, A.; Elliott, A.; McInnerney, K.; Spangler, C., New Two-Photon Activated Photodynamic Therapy Sensitizers Induce Xenograft Tumor Regressions after Near-IR Laser Treatment through the Body of the Host Mouse. Clin. Can. Res. 2008, 14, 6564–6573. DOI: 10.1158/1078-0432.CCR-07-4162.
  • Reinke, M.; Canakis, C.; Husain, D.; Michaud, M.; Flotte, T. J.; Gragoudas, E. S.; Miller, J. W., Verteporfin Photodynamic Therapy Retreatment of Normal Retina and Choroid in the Cynomolgus Monkey. Ophthalmology. 1999, 106, 1915–1923. DOI: 10.1016/S0161-6420(99)90401-3.
  • Midoux, P.; Pichon, C.; Yaouanc, -J.-J.; Jaffrès, J. A., Chemical Vectors for Gene Delivery: A Current Review on Polymers, Peptides and Lipids Containing Histidine or Imidazole as Nucleic Acids Carriers. Br. J. Pharmacol. 2009, 152, 166–178. DOI: 10.1111/j.1476-5381.2009.00288.x.
  • Maggioni, D.; Galli, M.; D’Alfonso, L.; Invers, D.; Dozzi, M. V.; Sironi, L.; Iannacone, M.; Collini, M.; Ferruti, P.; Ranucci, E.; et al., A Luminescent Poly(amidoamine)–Iridium Complex as A New Singlet-Oxygen Sensitizer for Photodynamic Therapy. Inorg. Chem. 2015, 54, 544–553. DOI: 10.1021/ic502378z.
  • Huang, N.; Wang, P.; Jiang, D. Covalent Organic Frameworks a Materials Platfrom for Structural and Functional Designs. Nat. Rev. 2016, 1. DOI: 10.1038/natrevmats.2016.68.
  • Ma, T.; Kapustin, E. A.; Yin, S. X.; Liang, L.; Zhou, Z.; Niu, J.; Li, L. H.; Wang, Y.; Su, J.; Li, J.; et al., Single-Crystal X-Ray Diffraction Structures of Covalent Organic Frameworks. Science. 2018, 361, 48–52. DOI: 10.1126/science.aat7679.
  • Cote, A. P.; Benin, A. I.; Ockwig, N. W.; O’Keeffe, M. O.; Matzger, A. J.; Yaghi, O. M., Porous, Crystalline, Covalent Organic Frameworks. Science. 2005, 310, 1166–1171. DOI: 10.1126/science.1120411.
  • Wang, D.; Zhou, J.; Shi, R.; Wu, H.; Chen, R.; Duan, B.; Xia, G.; Xu, P.; Wang, H.; Zhou, S.; et al., Biodegradable Core-Shell Dual-Metal-Organic-Frameworks Nanotheranostic Agent for Multiple Imaging Guided Combination Cancer Therapy. Theranostics. 2017, 7, 4605–4617. DOI: 10.7150/thno.20363.
  • Zhang, Y.; Lovell, J. F., Porphyrins as Theranostic Agents from Prehistoric to Modern Times. Theranostics. 2012, 2, 905–914. DOI: 10.7150/thno.4908.
  • Yang, Y.; Liu, J.; Liang, C.; Feng, L.; Fu, T.; Dong, Z.; Chao, Y.; Yonggang, L.; Lu, G.; Chen, M.; et al., Nanoscale Metal–Organic Particles with RapidClearance for Magnetic Resonance Imaging-Guided Photothermal Therapy. ACS Nano. 2016, 10, 2774–2781. DOI: 10.1021/acsnano.5b07882.
  • Faulknet, A.-S.; Rousseau, J. A.; Langlois, R.; Berard, V.; Lecomte, R.; Bénard, F.; van Lier, J. E. Copper-64 Labeled Sulfophthalocyanines for Positron Emis-Sion Tomography (PET) Imaging in Tumor-Bearing Rats. J. Porphyr Phthalocyanines. 2008, 12, 49–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.